Cargando…

Iron treatment and the TREAT trial

Treatment with erythropoiesis-stimulating agents (ESAs) enables the correction of anaemia in chronic kidney disease (CKD) patients, thus reducing its symptoms and complications. Not only is iron therapy aimed at correcting iron deficiency, but also it is an adjuvant therapy in CKD patients receiving...

Descripción completa

Detalles Bibliográficos
Autor principal:	Locatelli, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Supplement Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813788/ https://www.ncbi.nlm.nih.gov/pubmed/27046442 http://dx.doi.org/10.1093/ndtplus/sfr041

Ejemplares similares

The future of intravenous iron in nephrology
por: Coyne, Daniel W.
Publicado: (2011)

Iron Intake and Associated Factors in General Japanese Population: NIPPON DATA80, NIPPON DATA90 and National Nutrition Monitoring
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2010)

Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
por: Ruderman, Eric M., et al.
Publicado: (2012)

Retention, stability, iron bioavailability and sensory evaluation of extruded rice fortified with iron, folic acid and vitamin B(12)
por: Jyrwa, Yvette Wilda, et al.
Publicado: (2020)

Ongoing Trials of Simplified Antibiotic Regimens for the Treatment of Serious Infections in Young Infants in South Asia and Sub-Saharan Africa: Implications for Policy
por: Esamai, Fabian, et al.
Publicado: (2013)

Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids
por: Harrington, Amanda, et al.
Publicado: (2020)

Management of anaemia in CKD—the relative importance of erythropoietin and iron
por: Agarwal, Rajiv
Publicado: (2011)

The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
por: Page, Malcom G P
Publicado: (2019)

Commercially produced complementary foods in Bandung City, Indonesia, are often reported to be iron fortified but with less than recommended amounts or suboptimal forms of iron
por: Dreyfuss, Michele L., et al.
Publicado: (2019)

Treatment of Fast Breathing in Neonates and Young Infants With Oral Amoxicillin Compared With Penicillin–Gentamicin Combination: Study Protocol for a Randomized, Open-label Equivalence Trial
Publicado: (2013)

Abstract: Post-Operative Intravenous Iron Sucrose Versus Post-Operative Oral Iron to Treat Post-Bariatric Abdominoplasty Anaemia (ISAPA): A Prospective, Open-Label, Randomised Controlled Trial
por: Montano-Pedroso, Juan Carlos, et al.
Publicado: (2018)

Safety and Efficacy of Simplified Antibiotic Regimens for Outpatient Treatment of Serious Infection in Neonates and Young Infants 0–59 Days of Age in Bangladesh: Design of a Randomized Controlled Trial
por: Baqui, Abdullah H., et al.
Publicado: (2013)

Introducing iron isomaltoside 1000 (Monofer®)—development rationale and clinical experience
por: Kalra, Philip A.
Publicado: (2011)

Barriers and enablers for iron folic acid (IFA) supplementation in pregnant women
por: Siekmans, Kendra, et al.
Publicado: (2017)

Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials
por: Ruiz-Ojeda, Francisco Javier, et al.
Publicado: (2019)

Beyond efficacy and safety—the need for convenient and cost-effective iron therapy in health care
por: Bhandari, Sunil
Publicado: (2011)

Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
por: White, Michael, et al.
Publicado: (2011)

ES-2 Phase 3 TRIDENT Trial: Radiation and Temozolomide with or without Tumor Treating Fields in newly diagnosed glioblastoma
por: Nakada, Mitsutoshi
Publicado: (2020)

Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease
por: Ganz, Tomas, et al.
Publicado: (2023)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

Therapeutic Options in the Prevention and Treatment of Postmenopausal Osteoporosis
por: Kamel, Hosam K., et al.
Publicado: (2006)

Navigating changes in Clostridioides difficile prevention and treatment
por: Durham, Spencer H, et al.
Publicado: (2020)

Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs
por: Bektas, Meryem, et al.
Publicado: (2020)

Opioid Dependence: Managing the High Cost of Treatment Failure
por: Jan, Saira A.
Publicado: (2010)

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh P, et al.
Publicado: (2020)

Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing
por: Kimpen, Jan LL
Publicado: (2002)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

Treatment Strategies and Quality-of-Care Indicators for Patients With Parkinson's Disease
por: Chen, Jack J., et al.
Publicado: (2009)

ETMM-03. CANCER CELLS DEPLOY LIPOCALIN- 2 TO COLLECT LIMITING IRON IN LEPTOMENINGEAL METASTASIS
por: Chi, Yudan, et al.
Publicado: (2021)

Eosinophilic COPD: a Separate Disease Phenotype Warranting Specific Treatment
por: Koenderman, Leo
Publicado: (2017)

Eosinophilic COPD: a Separate Disease Phenotype Warranting Specific Treatment
por: Koenderman, Leo
Publicado: (2017)

Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David, et al.
Publicado: (2007)

Incretin Mimetics: Promising New Therapeutic Options in the Treatment of Type 2 Diabetes
por: Gleeson, Jeremy M., et al.
Publicado: (2005)

Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy
por: Yiannoutsos, Constantin Theodore, et al.
Publicado: (2012)

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2018)

Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease
por: Rao, Vamshi K., et al.
Publicado: (2018)

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease
por: Young, Melodie, et al.
Publicado: (2016)

Simplified Regimens for Management of Neonates and Young Infants With Severe Infection When Hospital Admission Is Not Possible: Study Protocol for a Randomized, Open-label Equivalence Trial
Publicado: (2013)

The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)
por: Morgante, Francesca, et al.
Publicado: (2019)

Treatment of Major Depressive Disorder in Patients Failing Initial Therapy: An Excel-Based Pharmacoeconomic Model
por: Malone, Daniel C., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_p7i63jfshu5t01ljnur9nnkvl1